These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3815819)

  • 1. Digoxin radioimmunoassay that does not detect digoxin-like substance in serum of newborns, infants, or patients with renal failure.
    Witherspoon L; Shuler S; Neely H; Sonnemaker R; Alyea K; Gilbert S
    Clin Chem; 1987 Mar; 33(3):420. PubMed ID: 3815819
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of digoxin-like immunoreactive substances on the "Dac-Cel" digoxin assay.
    Smith RL
    Clin Chem; 1987 Sep; 33(9):1697. PubMed ID: 3621591
    [No Abstract]   [Full Text] [Related]  

  • 3. Digoxin-like immunoreactive substance in renal failure: a reappraisal.
    Greenway DC; Nanji AA
    Nephron; 1986; 44(2):108-10. PubMed ID: 3774074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interference of digoxin-like immunoreactive substances with TDx digoxin II assay in different patients.
    Avendaño C; Alvarez JS; Sacristan JA; Adin J; Alsar MJ
    Ther Drug Monit; 1991 Nov; 13(6):523-7. PubMed ID: 1771650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endogenous digoxin-like substance level in essential arterial hypertension, renal failure and acromegaly].
    Soszyński P; Słowińska-Srzednicka J; Wierzbicki M
    Pol Arch Med Wewn; 1988 Jan; 79(1):20-5. PubMed ID: 3275165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Digoxin-like immunoreactive substances in urine and serum from preterm and term infants: relationship to renal excretion of sodium.
    Ebara H; Suzuki S; Nagashima K; Shimano S; Kuroume T
    J Pediatr; 1986 May; 108(5 Pt 1):760-2. PubMed ID: 3009770
    [No Abstract]   [Full Text] [Related]  

  • 7. Influence of assay methodologies and interferences on the interpretation of digoxin concentrations.
    Fitzsimmons WE
    Drug Intell Clin Pharm; 1986; 20(7-8):538-42. PubMed ID: 3755675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of blood digoxin].
    Janssen K
    Dtsch Med Wochenschr; 1990 Aug; 115(33):1254. PubMed ID: 2201511
    [No Abstract]   [Full Text] [Related]  

  • 9. Endogenous digoxin-immunoactive factor in human subjects.
    Valdes R
    Fed Proc; 1985 Sep; 44(12):2800-5. PubMed ID: 3839758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Digoxin-like substance(s) interfere(s) with serum estimations of the drug in cirrhotic patients.
    Nikou GC; Vyssoulis GP; Venetikou MS; Karga HI; Karoutsos KA; Toutouzas PK
    J Clin Gastroenterol; 1989 Aug; 11(4):430-3. PubMed ID: 2547866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous digoxin-like substances.
    J Pediatr; 1986 Nov; 109(5):910-1. PubMed ID: 3772672
    [No Abstract]   [Full Text] [Related]  

  • 12. Measuring endogenous digoxin-like substance and exogenous digoxin in the serum of low-birth-weight infants.
    Ng PK; LeGatt D; Coates J; Collins-Nakai RL
    Am J Hosp Pharm; 1985 Sep; 42(9):1977-9. PubMed ID: 3901741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific interaction between antidigoxin antibodies and digoxin-like immunoreactive substances in cord serum.
    Scherrmann JM; Sandouk P; Guedeney X
    Clin Chem; 1986 Jan; 32(1 Pt 1):97-100. PubMed ID: 3753588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tentative identification of a digoxin-like immunoreactive substance.
    Toseland PA; Oldfield PR; Murphy GM; Lawson AM
    Ther Drug Monit; 1988; 10(2):168-71. PubMed ID: 3381233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay of digoxin in serum using monoclonal antibodies and assessment of interference by digoxin-like immunoreactive substances.
    Loucari-Yiannakou E; Yiannakou L; Souvatzoglou A; Diamandis EP
    Ther Drug Monit; 1990 Mar; 12(2):195-200. PubMed ID: 2315977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digoxin-like immunoreactive factors eliminated from serum samples by hydrophobic silica-gel extraction and enzyme immunoassay.
    Skogen WF; Rea MR; Valdes R
    Clin Chem; 1987 Mar; 33(3):401-4. PubMed ID: 3545537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inaccuracies in digoxin measurement.
    Cook JD; Koch TR; Cook MS; Knoblock EC
    Clin Biochem; 1988 Dec; 21(6):353-7. PubMed ID: 3233747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW; Pudek MR; Humphries KH
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Developement and quality control of a radioimmunoassay for measurement of endogenous digoxin].
    Baz MJ; Vargas F; Haro JM; Castillo MA; Jódar E; Andrade JL; García del Río C
    Rev Esp Fisiol; 1990 Dec; 46(4):385-91. PubMed ID: 2099536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive substance in sera from umbilical cord, infants and mothers.
    Chen MR; Wu WH; Sung TC; Chen PN; Wang EY; Yang YC
    Taiwan Yi Xue Hui Za Zhi; 1987 Sep; 86(9):952-6. PubMed ID: 3694167
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.